Intraperitoneal chemotherapy: rationale, applications, and limitations.

about

Determinants and prognostic implications of malignant ascites in metastatic papillary renal cancer.Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model.

P2860

Q39133362-8C3C0004-CC80-4C47-91BE-9DC071AE4E15 Q48533666-C528DBB7-E78B-4B84-A3F9-57057A96C68E

P2860

Intraperitoneal chemotherapy: rationale, applications, and limitations.

Item

http://www.wikidata.org/entity/Q38156120

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Intraperitoneal chemotherapy: rationale, applications, and limitations.

@en

type

Item

label

Intraperitoneal chemotherapy: rationale, applications, and limitations.

@en

prefLabel

Intraperitoneal chemotherapy: rationale, applications, and limitations.

@en

P1476

Intraperitoneal chemotherapy: rationale, applications, and limitations.

@en

P2093

Mariam A Al-Badaineh

http://www.w3.org/2001/XMLSchema#string

Osama M Al-Quteimat

http://www.w3.org/2001/XMLSchema#string

P2860

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

Peritoneal Sarcomatosis Versus Peritoneal Carcinomatosis: Imaging Findings at MDCT

Intraperitoneal chemotherapy.

A review of peritoneal mesothelioma at the Washington Cancer Institute.

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Pseudomyxoma peritonei.

New approach to peritoneal surface malignancies

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials.

Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.

P304

369-380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1078155213506244

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258115902

http://www.w3.org/2001/XMLSchema#string

P698

24166789

http://www.w3.org/2001/XMLSchema#string

Intraperitoneal chemotherapy: rationale, applications, and limitations.

about

P2860

P2860

Intraperitoneal chemotherapy: rationale, applications, and limitations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698